Ackermans & Van Haaren NV

Price Chart

Risk-Adjusted Performance

Also Listed On

Ackermans & Van Haaren NV (ACKB) Price Performance

Ackermans & Van Haaren NV (ACKB) trades on BR in EUR. The company is classified in the Industrials sector under the Engineering & Construction industry. The stock currently trades at EUR262.20, up 1.94% from the previous close.

Over the past year, ACKB has traded between a low of EUR176.41 and a high of EUR298.00. The stock has gained 29.1% over this period. It is currently 12.0% below its 52-week high.

Ackermans & Van Haaren NV has a market capitalization of $8.77B, with a price-to-earnings ratio of 14.81 and a dividend yield of 1.70%.

About Ackermans & Van Haaren NV

Ackermans & Van Haaren NV engages in the marine engineering and contracting, private banking, real estate and senior care, energy and resources, and growth capital businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; and specialized advisory banking services for entrepreneurs and liberal professionals, as well as financing and financial leasing services for cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and residential, retail, and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital segment provides engineering and solutions in production process automation; validation and compliance services; compact biogas installation; specialty chemicals; broadcast and media solutions for sports, entertainment, and events; online and printed news; and logistics services for rail, port and road transport, and intermodal transport, and warehousing. It also develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, as well as distributes aftermarket products. The company also develops medical devices and medicines for the treatment of cancer and genetic diseases. The company was founded in 1876 and is based in Antwerp, Belgium.